People may well compare car performance figures before buying, but I doubt many patients even think of doing so when it comes to medicines and drugs. The reason is that they trust the regulators (and their doctor) to ensure that all products work properly on the market. But why should a regulator of medicines be better than any other bureaucrat in any other field?
I’ve long wished Microbe Hunters could be updated in a way that more fully contextualizes the researchers’ work and achievements. In reading Thomas Goetz’s The Remedy this weekend, I felt that my wish was finally granted.
Biotech researchers and investors – to say nothing of the patients waiting desperately for new medicines – may conclude from the latest New Yorkerthat their problems are over.
When providing care and offering advice, should a physician think only of the patient in front of her, or does she have an obligation to balance the needs of the individual patient with the broader needs of society?
Perhaps there’s hope for medicine’s future after all.
If medicine has become as odious a profession as many practitioners seem to suggest, why are the number of medical school applicants and enrollees at an all-time high?
Senate Democrats have been desperately trying to move the national conversation away from Obamacare to just about anything else before the midterm elections — “paycheck fairness,” the minimum wage, even the Koch brothers.
Join a diverse group of panelists — including sociologists, education experts, and students — for a discussion of how public policy and culture can help families lay a firmer foundation for their children’s educational success, and of how the effects of paternal involvement vary by socioeconomic background.
This event will coincide with the release of a new report by AEI’s Mary Habeck, which analyzes why current national security policy is failing to stop the advancement of al Qaeda and its affiliates and what the US can do to develop a successful strategy to defeat this enemy.
During this event, experts with many different views on the ACA will offer their predictions for the future.